Back

Chronic kidney disease and survival of patients with tricuspid regurgitation

28 August 2023 (12:45 - 12:54)
Organised by: Logo
Congress Presentation Part of: Who are the optimal candidates for tricuspid transcatheter edge-to-edge valve repair? Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Mr Ranel Loutati

Sheba Medical Center, Ramat Gan (Israel)

4 More presentations in this session

Presentation thumbnail
Long-term outcomes of transcatheter tricuspid valve repair in prohibitive risk patients: futility or benefit?
Doctor I. Patrascu (Oldenburg, DE)
Abstract Slides Video
Presentation thumbnail
Right heart function in isolated severe tricuspid regurgitation. a new stratification approach by Speckle tracking echocardiography
Mrs R. Hinojar Baydes (Madrid, ES)
Abstract Slides Video
Presentation thumbnail
Right ventricular-pulmonary arterial coupling for predicting death or heart failure admission in a broad population of patients with severe tricuspid regurgitation: data from the INTRICOR registry.
Doctor C. Fernandez-Aviles Irache (Madrid, ES)
Abstract Slides Video
Presentation thumbnail
Hemodynamic implications of transcatheter tricuspid valve repair in HFpEF Patients - HERACLES-HFpEF
Doctor K. Kresoja (Mainz, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Who are the optimal candidates for tricuspid transcatheter edge-to-edge valve repair?
Video

The Event

Event poster

ESC Congress 2023

28 August 2023 12:45 CET
You may be interested in
thumbnail
Congress Session
Tricuspid valve intervention: ready for prime time?
31 August 2024
thumbnail
Congress Presentation
Kidney function and coronary artery disease
29 August 2025
thumbnail
Congress Presentation
Chronic kidney disease and severe mitral regurgitation: outcomes of edge-to-edge repair in high-risk patients
18 May 2025
thumbnail
Congress Presentation
TAVI versus SAVR in intermediate-risk patients with severe aortic stenosis and chronic kidney disease: a matched comparison in a subcohort from the GARY registry
28 August 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources